MoneyLion secures $22.5M to bring fresh talent to AI finance management Stay up-to-date on the topics you care about. We'll send you an email alert whenever a news article matches your alert term. It's free, and you can add new alerts at any time. We won't share your personal information with anyone.
Machine-learning technology has beaten humans at games of chess and Go to worldwide fanfare. A demonstration of its eerily lifelike prowess in making phone calls to unsuspecting people went viral. But a less-noticed win for DeepMind, the artificial-intelligence arm of Google's parent Alphabet Inc., at a biennial biology conference could upend how drugmakers find and develop new medicines. It could also dial up pressure on the world's largest pharmaceutical companies to prepare for a technological arms race. Already, a new breed of upstarts are jumping into the fray.
US-based tech giant Apple has now acquired Tuplejump, a Hyderabad-based machine-learning startup that had been helping companies stock, process and visualizes big data with its unique software. With the India/US based company, Apple has now acquired three machine-learning companies within a short window of two years so as to expand its reach into artificial intelligence technology. According to a report on Techcrunch, the Shares of Apple (AAPL) had been continuously increasing in the afternoon trading on Thursday following the companies agreement to purchase Tuplejump, citing sources. Two co-founders of the Machine Learning startup (founded in 2013), Rohit Rai and Satyaprakash Buddhavarapu are already reported to have joined Apple while the third co-founder, Deepak Alur has joined Anaplan that is a Cloud-based business planning platform for finance, operations, and sales. Apple had been particularly interested in an open source project titled "FiloDB" that Tuplejump was currently working on so as to efficiently apply the machine learning concepts along with analytics to complex data.